» Authors » Nizar Jarjour

Nizar Jarjour

Explore the profile of Nizar Jarjour including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 1543
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Fowler S, Shaw D, Adcock I, Sousa A, Djukanovic R, et al.
Allergy Asthma Immunol Res . 2024 Aug; 16(4):338-352. PMID: 39155735
Purpose: Asthma is a clinical syndrome with various underlying pathomechanisms and clinical phenotypes. Genetic, ethnic, and geographic factors may influence the differences in clinical presentation, severity, and prognosis. We compared...
2.
Schiebler M, Tsuchiya N, Hahn A, Fain S, Denlinger L, Jarjour N, et al.
Adv Exp Med Biol . 2023 Jul; 1426:163-184. PMID: 37464121
The imaging of asthma using chest computed tomography (CT) is well-established (Jarjour et al., Am J Respir Crit Care Med 185(4):356-62, 2012; Castro et al., J Allergy Clin Immunol 128:467-78,...
3.
Tattersall M, Esnault S, Stewart R, Vereide D, Swanson S, Zhang J, et al.
J Am Heart Assoc . 2023 Jul; 12(14):e030139. PMID: 37449574
No abstract available.
4.
Gaston B, Gardner D, Mahan K, Akuthota P, Mendonca E, Durrington H, et al.
ERJ Open Res . 2023 Jun; 9(3). PMID: 37260461
Background: Many patients have uncontrolled asthma despite available treatments. Most of the new asthma therapies have focused on type 2 (T2) inflammation, leaving an unmet need for innovative research into...
5.
Gauthier M, Kale S, Oriss T, Gorry M, Ramonell R, Dalton K, et al.
J Allergy Clin Immunol . 2023 Mar; 152(1):94-106.e12. PMID: 36893862
Background: Type 1 (T1) inflammation (marked by IFN-γ expression) is now consistently identified in subsets of asthma cohorts, but how it contributes to disease remains unclear. Objective: We sought to...
6.
Tao R, Burivalova Z, Masri S, Dharmavaram N, Baber A, Deano R, et al.
Egypt Heart J . 2022 May; 74(1):37. PMID: 35527310
Background: Right ventricular (RV) dilation has been used to predict adverse outcomes in acute pulmonary conditions. It has been used to categorize the severity of novel coronavirus infection (COVID-19) infection....
7.
Geng B, Dixon A, Ko J, Janampally P, Haselkorn T, Holweg C, et al.
Ann Allergy Asthma Immunol . 2022 Feb; 128(5):553-560. PMID: 35101644
Background: Effectiveness of asthma treatment, including biologics, may be different in patients with higher body mass index (BMI). Objective: To evaluate response to omalizumab (dosed by serum immunoglobulin E level...
8.
Ortega V, Daya M, Szefler S, Bleecker E, Chinchilli V, Phipatanakul W, et al.
Lancet Child Adolesc Health . 2021 Nov; 5(12):862-872. PMID: 34762840
Background: Pharmacogenetic studies in asthma cohorts, primarily made up of White people of European descent, have identified loci associated with response to inhaled beta agonists and corticosteroids (ICSs). Differences exist...
9.
Chipps B, Jarjour N, Calhoun W, Iqbal A, Haselkorn T, Yang M, et al.
Ann Am Thorac Soc . 2021 Apr; 18(12):1978-1987. PMID: 33891831
Blood eosinophil counts are used to inform diagnosis/management of eosinophilic asthma. Examine blood eosinophil variability and identify factors affecting eosinophil levels to inform clinical interpretation. analysis to understand eosinophil variability...
10.
Hastie A, Mauger D, Denlinger L, Coverstone A, Castro M, Erzurum S, et al.
Am J Respir Crit Care Med . 2021 Feb; 203(7):882-892. PMID: 33545021
Some reports indicate longitudinal variability in sputum differential cell counts, whereas others describe stability. Highly variable sputum eosinophil percentages are associated with greater lung function loss than persistently elevated eosinophil...